GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurobiological Technologies Inc (OTCPK:NTII) » Definitions » Cyclically Adjusted PB Ratio

Neurobiological Technologies (Neurobiological Technologies) Cyclically Adjusted PB Ratio : (As of Jun. 07, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Neurobiological Technologies Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Neurobiological Technologies Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Neurobiological Technologies's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurobiological Technologies Cyclically Adjusted PB Ratio Chart

Neurobiological Technologies Annual Data
Trend Jun00 Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07 Jun08 Jun09
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Neurobiological Technologies Quarterly Data
Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Neurobiological Technologies's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Neurobiological Technologies's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neurobiological Technologies's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neurobiological Technologies's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Neurobiological Technologies's Cyclically Adjusted PB Ratio falls into.



Neurobiological Technologies Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Neurobiological Technologies's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2009 is calculated as:

For example, Neurobiological Technologies's adjusted Book Value per Share data for the three months ended in Sep. 2009 was:

Adj_Book=Book Value per Share/CPI of Sep. 2009 (Change)*Current CPI (Sep. 2009)
=1.072/91.1196*91.1196
=1.072

Current CPI (Sep. 2009) = 91.1196.

Neurobiological Technologies Quarterly Data

Book Value per Share CPI Adj_Book
199912 0.199 71.008 0.255
200003 0.538 72.231 0.679
200006 3.139 72.737 3.932
200009 2.868 73.286 3.566
200012 3.670 73.413 4.555
200103 3.209 74.341 3.933
200106 3.968 75.100 4.814
200109 3.711 75.227 4.495
200112 3.415 74.552 4.174
200203 3.012 75.438 3.638
200206 2.361 75.902 2.834
200209 2.344 76.366 2.797
200212 1.825 76.324 2.179
200303 1.641 77.716 1.924
200306 1.413 77.505 1.661
200309 1.095 78.138 1.277
200312 0.743 77.758 0.871
200403 5.773 79.066 6.653
200406 5.997 80.037 6.827
200409 6.361 80.121 7.234
200412 5.761 80.290 6.538
200503 4.833 81.555 5.400
200506 1.487 82.062 1.651
200509 2.403 83.876 2.611
200512 2.619 83.032 2.874
200603 1.754 84.298 1.896
200606 -2.760 85.606 -2.938
200609 -3.278 85.606 -3.489
200612 -3.973 85.142 -4.252
200703 -4.407 86.640 -4.635
200706 -4.763 87.906 -4.937
200709 -0.769 87.964 -0.797
200712 1.024 88.616 1.053
200803 0.844 90.090 0.854
200806 0.745 92.320 0.735
200809 0.631 92.307 0.623
200812 0.299 88.697 0.307
200903 0.290 89.744 0.294
200906 0.865 91.003 0.866
200909 1.072 91.120 1.072

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Neurobiological Technologies  (OTCPK:NTII) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Neurobiological Technologies Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Neurobiological Technologies's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurobiological Technologies (Neurobiological Technologies) Business Description

Traded in Other Exchanges
N/A
Address
2010 Crow Canyon Place, Suite 100, San Ramon, CA, USA, 94583
Neurobiological Technologies Inc is a biopharmaceutical company historically focused on developing investigational drugs for central nervous system conditions.
Executives
Ariel Warszawski 10 percent owner C/O FIREFLY VALUE PARTNERS, LP, 551 FIFTH AVENUE, 36TH FLOOR, NEW YORK NY 10176
Ryan Heslop 10 percent owner C/O FIREFLY VALUE PARTNERS, LP, 551 FIFTH AVENUE, 36TH FLOOR, NEW YORK NY 10176
Firefly Management Co Gp, Llc 10 percent owner C/O FIREFLY VALUE PARTNERS, LP, 551 FIFTH AVENUE, 36TH FLOOR, NEW YORK NY 10176
Fvp Gp, Llc 10 percent owner C/O FIREFLY VALUE PARTNERS, LP, 551 FIFTH AVENUE, 36TH FLOOR, NEW YORK NY 10176
Firefly Value Partners, Lp 10 percent owner 426 PINEVILLE ROAD, UNIT 1, NEWTOWN PA 18940
Fvp Master Fund Lp 10 percent owner FVP GP LLC, 551 FIFTH AVENUE, 36TH FLOOR, New York NY 10176
John B Stuppin director
Abraham E Cohen director 500 SEVENTH AVE 10TH FL, C/O AXONYX INC, NEW YORK NY 10018
Abraham D Sofaer director HOOVER INSTITUTION, STANFORD UNIVERSITY, STANFORD CA 94305-6010
Biotechnology Value Fund L P other: Direct Beneficial Owner 44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104
Bvf Partners L P/il 10 percent owner 44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104
Bvf Inc/il 10 percent owner 44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104
Biotechnology Value Fund Ii Lp other: Direct Beneficial Owner 44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104
Bvf Investments Llc other: Direct Beneficial Owner 1 SANSOME ST, 30TH FL, SAN FRANCISCO CA 94104
Mark N Lampert 10 percent owner 1 SANSOME ST, 30TH FL, SAN FRANCISCO CA 94104

Neurobiological Technologies (Neurobiological Technologies) Headlines